Skip to content

Apyx Medical Corporation APYX Surgical Aesthetics — Sales Commissions And Fees

Similar metrics at other companies

Bausch + Lomb logo
BLCOSurgical — Selling, general and administrative (Note 4)
$73M0.0%
GCM Grosvenor Inc. logo
GCMGSales Commissions And Fees
$1.2M-12.7%
U-Haul Holding logo
UHALSales Commissions And Fees
$81.58M+1.0%
Radiant Logistics logo
RLGTSales Commissions And Fees
$19.14M-0.6%
Surgery Partners, Inc. logo
SGRYSurgical Facilities — Salaries and benefits
$247.4M+3.7%
IAR
IARTSpecialty Surgery — SG&A
$77.68M-7.3%

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
Enterprise value$189.4M+101%
P/S3.2×+1.4×

Profitability

See full
Gross margin61.9%-3.1pp
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Where this comes from

Reported directly by Apyx Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:SalesCommissionsAndFees.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's surgical aesthetics — sales commissions and fees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's surgical aesthetics — sales commissions and fees?
Apyx Medical Corporation (APYX) reported surgical aesthetics — sales commissions and fees of $1.07M in Q1 2026.
What does surgical aesthetics — sales commissions and fees mean?
This metric tracks the variable costs associated with compensating sales personnel and third-party agents for generating revenue within the Surgical Aesthetics segment. It reflects the efficiency and cost-to-acquire dynamics of the segment's sales distribution model.